Literature DB >> 6386133

Reticulum cell sarcoma with unusual presenting features: fever and low cerebrospinal fluid glucose levels.

M J Wong, R M Chan, S N Stordy.   

Abstract

Reticulum cell sarcoma of the central nervous system usually presents as a focal mass lesion. A patient is described who presented with declining intellectual function, fever, and low glucose levels and pleocytosis in the cerebrospinal fluid, which initially suggested an infectious process. This clinical presentation has not been documented previously. The patient's condition improved following treatment with dexamethasone and radiation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6386133      PMCID: PMC1483736     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  6 in total

1.  Primary malignant lymphomas of the central nervous system.

Authors:  J M Henry; R R Heffner; S H Dillard; K M Earle; R L Davis
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

2.  The reticulum cell sarcoma--microglioma group of brain tumours. A consideration of their clinical features and therapy.

Authors:  H H Schaumburg; C R Plank; R D Adams
Journal:  Brain       Date:  1972       Impact factor: 13.501

3.  Reticulum cell sarcoma of the brain. A review of the literature and a study of 19 cases.

Authors:  P Littman; C C Wang
Journal:  Cancer       Date:  1975-05       Impact factor: 6.860

4.  Intracranial reticulum cell sarcoma associated with immunoglobulin A deficiency.

Authors:  M C Gregory; J T Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-10       Impact factor: 10.154

5.  Primary reticulum-cell sarcoma (microglioma) of the brain with massive cardiac metastasis. Case report.

Authors:  I Benjamin; M E Case
Journal:  J Neurosurg       Date:  1980-11       Impact factor: 5.115

6.  Cerebral reticulum cell sarcoma after multiple renal transplants.

Authors:  L B Barnett; E Schwartz
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-08       Impact factor: 10.154

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.